Total Funding
44
13
Total FundingGrant raised
Growth Score
-3 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
454329
ImStem Biotechnology is a drug-research platform designed to focus on treatment of heart, vascular and blood system and autoimmune diseases.
Michael Men: CEO
Richard Kim: Chief Medical OfficerPast Role: Xenoport, Chief Medical Officer and Senior VP, Clinical Development and Medical Affairs
About the Company
Imstem Biotechnology is a drug-research platform designed to focus on treatment of heart, vascular and blood system and autoimmune diseases. The company's drug-research platform produces cell therapeutic products from human embryonic stem cells to repair damaged tissues, enabling doctors to cure heart, vascular and blood system and autoimmune
diseases
